{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T18:09:32Z","timestamp":1758823772136,"version":"3.37.3"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,4]],"date-time":"2020-08-04T00:00:00Z","timestamp":1596499200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,4]],"date-time":"2020-08-04T00:00:00Z","timestamp":1596499200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CEN Case Rep"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s13730-020-00513-6","type":"journal-article","created":{"date-parts":[[2020,8,4]],"date-time":"2020-08-04T20:02:22Z","timestamp":1596571342000},"page":"46-52","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Low-dose corticosteroid with mizoribine might be an effective therapy for elderly-onset ISKDC grade VI IgA vasculitis"],"prefix":"10.1007","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6468-0127","authenticated-orcid":false,"given":"Hikaru","family":"Sugimoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiho","family":"Matsuno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriko","family":"Yamanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wako","family":"Yumura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuyo","family":"Itabashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Takei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,8,4]]},"reference":[{"key":"513_CR1","doi-asserted-by":"crossref","first-page":"e0196955","DOI":"10.1371\/journal.pone.0196955","volume":"13","author":"H Komatsu","year":"2018","unstructured":"Komatsu H, Fujimoto S, Maruyama S, et al. Distinct characteristics and outcomes in elderly-onset IgA vasculitis (Henoch-Sch\u00f6nlein Purpura) with nephritis: nationwide cohort study of data from the Japan Renal Biopsy Registry (J-RBR). PLoS ONE. 2018;13:e0196955.","journal-title":"PLoS ONE"},{"key":"513_CR2","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2169\/internalmedicine.1379-18","volume":"58","author":"H Ueda","year":"2019","unstructured":"Ueda H, Miyazaki Y, Tsuboi N, et al. Clinical and pathological characteristics of elderly japanese patients with IgA vasculitis with nephritis: a case series. Intern Med. 2019;58:31\u20138.","journal-title":"Intern Med"},{"key":"513_CR3","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2174\/1874372201408010051","volume":"8","author":"K Hitomi","year":"2014","unstructured":"Hitomi K, Izaki S, Teraki Y, et al. Characterization of adult-type IgA vasculitis (Henoch-Sch\u00f6nlein Purpura): a retrospective study of 122 cases. Open Dermatol J. 2014;8:51\u20139.","journal-title":"Open Dermatol J"},{"key":"513_CR4","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1097\/01.ASN.0000013883.99976.22","volume":"13","author":"E Pillebout","year":"2002","unstructured":"Pillebout E, Thervet E, Hill G, Alberti C, Vanhille P, Nochy D. Henoch-Schonlein Purpura in adults: outcome and prognostic factors. J Am Soc Nephrol. 2002;13:1271\u20138.","journal-title":"J Am Soc Nephrol"},{"key":"513_CR5","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.autrev.2015.02.003","volume":"14","author":"A Audemard-Verger","year":"2015","unstructured":"Audemard-Verger A, Pillebout E, Guillevin L, Thervet E, Terrier B. IgA vasculitis (Henoch\u2013Sh\u00f6nlein Purpura) in adults: diagnostic and therapeutic aspects. Autoimmun Rev. 2015;14:579\u201385.","journal-title":"Autoimmun Rev"},{"key":"513_CR6","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nrneph.2014.126","volume":"10","author":"JC Davin","year":"2014","unstructured":"Davin JC, Coppo R. Henoch-Sch\u00f6nlein Purpura nephritis in children. Nat Rev Nephrol. 2014;10:563\u201373.","journal-title":"Nat Rev Nephrol"},{"key":"513_CR7","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1007\/s00431-019-03409-5","volume":"178","author":"C Roman","year":"2019","unstructured":"Roman C, Dima B, Muyshont L, Schurmans T, Gilliaux O. Indications and efficiency of Dapsone in IgA vasculitis (Henoch-Schonlein Purpura): case series and a review of the literature. Eur J Pediatr. 2019;178:1275\u201381.","journal-title":"Eur J Pediatr"},{"key":"513_CR8","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s13730-016-0227-0","volume":"5","author":"E Sasaki","year":"2016","unstructured":"Sasaki E, Shibata M, Kato A, et al. An adult case of severe steroid-resistant Henoch-Sch\u00f6nlein Purpura nephritis treated with intravenous cyclophosphamide and tonsillectomy. CEN Case Rep. 2016;5:212\u20138.","journal-title":"CEN Case Rep"},{"key":"513_CR9","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/art.40339","volume":"70","author":"F Maritati","year":"2018","unstructured":"Maritati F, Fenoglio R, Pillebout E, et al. Brief report: Rituximab for the treatment of adult-Onset IgA vasculitis (Henoch-Sch\u00f6nlein). Arthritis Rheumatol. 2018;70:109\u201314.","journal-title":"Arthritis Rheumatol"},{"key":"513_CR10","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s12026-016-8827-5","volume":"65","author":"R Fenoglio","year":"2017","unstructured":"Fenoglio R, Naretto C, Basolo B, et al. Rituximab therapy for IgA-vasculitis With nephritis: a case series and review of the literature. Immunol Res. 2017;65:186\u201392.","journal-title":"Immunol Res"},{"key":"513_CR11","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1002\/art.40178","volume":"69","author":"A Audemard-Verger","year":"2017","unstructured":"Audemard-Verger A, Terrier B, Dechartres A, et al. Characteristics and management of IgA vasculitis (Henoch-Sch\u00f6nlein) in adults: data from 260 patients included in a french multicenter retrospective survey. Arthritis Rheumatol. 2017;69:1862\u201370.","journal-title":"Arthritis Rheumatol"},{"key":"513_CR12","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.2340\/00015555-2733","volume":"97","author":"LE Hetland","year":"2017","unstructured":"Hetland LE, Susrud KS, Lindahl KH, Bygum A. Henoch-Sch\u00f6nlein Purpura: a literature review. Acta Derm Venereol. 2017;97:1160\u20136.","journal-title":"Acta Derm Venereol"},{"key":"513_CR13","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13075-016-0959-4","volume":"18","author":"A Ho\u010devar","year":"2016","unstructured":"Ho\u010devar A, Rotar Z, Jur\u010di\u0107 V, et al. IgA vasculitis in adults: the performance of the EULAR\/PRINTO\/PRES classification criteria in adults. Arthritis Res Ther. 2016;18:58.","journal-title":"Arthritis Res Ther"},{"key":"513_CR14","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1007\/s10157-012-0673-8","volume":"16","author":"H Yokoyama","year":"2012","unstructured":"Yokoyama H, Sugiyama H, Sato H, et al. Renal disease in the elderly and the very elderly Japanese: analysis of the Japan Renal Biopsy Registry (J-RBR). Clin Exp Nephrol. 2012;16:903\u201320.","journal-title":"Clin Exp Nephrol"},{"key":"513_CR15","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s42358-019-0064-x","volume":"59","author":"V Schinzel","year":"2019","unstructured":"Schinzel V, Fernandez JD, Clemente G, et al. The profile and clinical outcomes of patients with renal involvement due to IgA vasculitis: is azathioprine a good option for treatment? Adv Rheumatol. 2019;59:21.","journal-title":"Adv Rheumatol"},{"key":"513_CR16","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1111\/j.1600-0560.2008.01145.x","volume":"36","author":"T Nagasaka","year":"2009","unstructured":"Nagasaka T, Miyamoto J, Ishibashi M, Chen KR. MPO-ANCA- and IgA-positive systemic vasculitis: a possibly overlapping syndrome of microscopic polyangiitis and Henoch-Schoenlein Purpura. J Cutan Pathol. 2009;36:871\u20137.","journal-title":"J Cutan Pathol"},{"key":"513_CR17","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2015-210121","author":"V Bernardino","year":"2015","unstructured":"Bernardino V, Mendes-Bastos P, Rodrigues A, Riso N. IgA vasculitis (formerly Henoch-Sch\u00f6nlein Purpura) in an adult with systemic lupus erythematosus. BMJ Case Rep. 2015. https:\/\/doi.org\/10.1136\/bcr-2015-210121.","journal-title":"BMJ Case Rep"},{"key":"513_CR18","first-page":"38","volume":"110","author":"JB Berquist","year":"2011","unstructured":"Berquist JB, Bartels CM. Rare association of Henoch-Sch\u00f6nlein Purpura with recurrent endocarditis. WMJ. 2011;110:38\u201340.","journal-title":"WMJ"},{"key":"513_CR19","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1136\/bmj.2.6078.11","volume":"2","author":"R Counahan","year":"1977","unstructured":"Counahan R, Winterborn MH, White RH, et al. Prognosis of Henoch-Schonlein nephritis in children. Br Med J. 1977;2:11\u20134.","journal-title":"Br Med J"},{"key":"513_CR20","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1681\/ASN.V10122637","volume":"10","author":"A Rai","year":"1999","unstructured":"Rai A, Nast C, Adler S. Henoch-Sch\u00f6nlein Purpura nephritis. J Am Soc Nephrol. 1999;10:2637\u201344.","journal-title":"J Am Soc Nephrol"},{"key":"513_CR21","doi-asserted-by":"crossref","first-page":"c199","DOI":"10.1159\/000218109","volume":"112","author":"O Soylemezoglu","year":"2009","unstructured":"Soylemezoglu O, Ozkaya O, Ozen S, et al. Henoch-Sch\u00f6nlein Nephritis: a nationwide study. Nephron Clin Pract. 2009;112:c199\u2013204.","journal-title":"Nephron Clin Pract"},{"key":"513_CR22","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/s12519-014-0527-4","volume":"11","author":"YJ Huang","year":"2015","unstructured":"Huang YJ, Yang XQ, Zhai WS, et al. Clinicopathological features and prognosis of membranoproliferative-like Henoch-Sch\u00f6nlein Purpura nephritis in children. World J Pediatr. 2015;11:338\u201345.","journal-title":"World J Pediatr"},{"key":"513_CR23","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1007\/s00467-019-04238-2","volume":"34","author":"M Koskela","year":"2019","unstructured":"Koskela M, Jahnukainen T, End\u00e9n K, et al. Methylprednisolone or cyclosporine a in the treatment of Henoch-Sch\u00f6nlein nephritis: a nationwide study. Pediatr Nephrol. 2019;34:1447\u2013566.","journal-title":"Pediatr Nephrol"},{"key":"513_CR24","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1007\/s11255-009-9701-3","volume":"42","author":"Y Kawasaki","year":"2010","unstructured":"Kawasaki Y, Suyama K, Yugeta E, et al. The incidence and severity of Henoch-Sch\u00f6nlein Purpura nephritis over a 22-year period in Fukushima Prefecture. Japan Int Urol Nephrol. 2010;42:1023\u20139.","journal-title":"Japan Int Urol Nephrol"},{"key":"513_CR25","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1007\/s10157-015-1177-0","volume":"20","author":"H Komatsu","year":"2016","unstructured":"Komatsu H, Fujimoto S, Yoshikawa N, Kitamura H, Sugiyama H, Yokoyama H. Clinical manifestations of Henoch-Sch\u00f6nlein Purpura nephritis and iga nephropathy: comparative analysis of data from the Japan Renal Biopsy Registry (J-RBR). Clin Exp Nephrol. 2016;20:552\u201360.","journal-title":"Clin Exp Nephrol"},{"key":"513_CR26","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/nep.12558","volume":"21","author":"M Kaneko","year":"2015","unstructured":"Kaneko M, Ikezumi Y, Yamada T, Hasegawa H, Kaneko U, Saitoh A. Local leukocyte proliferation as a target for cyclophosphamide in the treatment of Henoch-Sch\u00f6nlein Purpura nephritis grade VI. Nephrology (Carlton). 2015;21:68\u201371.","journal-title":"Nephrology (Carlton)"},{"key":"513_CR27","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1007\/s00467-003-1292-0","volume":"18","author":"JC Davin","year":"2003","unstructured":"Davin JC, Weening JJ. Diagnosis of Henoch-Sch\u00f6nlein Purpura: renal or skin biopsy? Pediatr Nephrol. 2003;18:1201\u20133.","journal-title":"Pediatr Nephrol"},{"key":"513_CR28","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/ckj\/sfz006","volume":"J12","author":"A Navaratnarajah","year":"2019","unstructured":"Navaratnarajah A, Sambasivan K, Cook TH, Pusey C, Roufosse C, Willicombe M. Predicting long-term renal and patient survival by clinicopathological features in elderly patients undergoing a renal biopsy in a UK cohort. Clin Kidney. 2019;J12:512\u201320.","journal-title":"Clin Kidney"},{"key":"513_CR29","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000336307","volume":"35","author":"E Verde","year":"2012","unstructured":"Verde E, Quiroga B, Rivera F, L\u00f3pez-G\u00f3mez JM. Renal biopsy in very elderly patients: data from the Spanish registry of glomerulonephritis. Am J Nephrol. 2012;35:230\u20137.","journal-title":"Am J Nephrol"},{"key":"513_CR30","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nrneph.2009.145","volume":"5","author":"JA Jefferson","year":"2009","unstructured":"Jefferson JA, Alpers CE. Diagnosis: should renal biopsies be performed in the very elderly? Nat Rev Nephrol. 2009;5:561\u20132.","journal-title":"Nat Rev Nephrol"},{"key":"513_CR31","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.2215\/CJN.00990209","volume":"4","author":"DA Moutzouris","year":"2009","unstructured":"Moutzouris DA, Herlitz L, Appel GB, et al. Renal biopsy in the very elderly. Clin J Am Soc Nephrol. 2009;4:1073\u201382.","journal-title":"Clin J Am Soc Nephrol"},{"key":"513_CR32","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1007\/s10157-008-0036-7","volume":"12","author":"M Koike","year":"2008","unstructured":"Koike M, Takei T, Uchida K, et al. Clinical assessment of low-dose steroid therapy for patients with IgA nephropathy: a prospective study in a single center. Clin Exp Nephrol. 2008;12:250\u20135.","journal-title":"Clin Exp Nephrol"},{"key":"513_CR33","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1093\/clinids\/11.6.954","volume":"11","author":"AE Stuck","year":"1989","unstructured":"Stuck AE, Minder CE, Frey FJ. Risk of infectious complications in patients taking glucocorticosteroids. Rev Infect Dis. 1989;11:954\u201363.","journal-title":"Rev Infect Dis"},{"key":"513_CR34","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s001980200108","volume":"13","author":"TP Van Staa","year":"2002","unstructured":"Van Staa TP, Leufkens HGM, Cooper C. The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. Osteoporos Int. 2002;13:777\u201387.","journal-title":"Osteoporos Int"},{"key":"513_CR35","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1093\/rheumatology\/39.12.1383","volume":"39","author":"TP Van Staa","year":"2000","unstructured":"Van Staa TP, Leufkens HG, Abenhaim L, Zhang B, Cooper C. Oral corticosteroids and fracture risk: relationship to daily and cumulative doses. Rheumatology (Oxford). 2000;39:1383\u20139.","journal-title":"Rheumatology (Oxford)"},{"key":"513_CR36","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/0091-6749(85)90708-0","volume":"76","author":"SL Bowyer","year":"1985","unstructured":"Bowyer SL, LaMothe MP, Holiiiter JR. Steroid myopathy: incidence and detection in a population with asthma. J Allergy Clin Immunol. 1985;76:234\u201342.","journal-title":"J Allergy Clin Immunol"},{"key":"513_CR37","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1007\/s00296-017-3685-6","volume":"37","author":"A Mima","year":"2017","unstructured":"Mima A. Efficacy of mizoribine and prednisolone combination therapy in adult patients with IgA vasculitis. Rheumatol Int. 2017;37:1387\u201393.","journal-title":"Rheumatol Int"},{"key":"513_CR38","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1620\/tjem.211.291","volume":"211","author":"Y Kawasaki","year":"2007","unstructured":"Kawasaki Y, Suyama K, Matsumoto A, et al. Efficacy of tonsillectomy plus methylprednisolone pulse therapy for a child with Henoch-Schoenlein Purpura nephritis. Tohoku J Exp Med. 2007;211:291\u20135.","journal-title":"Tohoku J Exp Med"},{"key":"513_CR39","first-page":"212","volume":"146","author":"T Kawakami","year":"2010","unstructured":"Kawakami T, Shirai S, Kimura K, Soma Y. Successful use of mizoribine to treat recurrent corticosteroid-resistant palpable purpura in a patient with Henoch Schonlein Purpura nephritis. Arch Dermatol. 2010;146:212\u20133.","journal-title":"Arch Dermatol"},{"key":"513_CR40","doi-asserted-by":"crossref","first-page":"157","DOI":"10.5387\/fms.56.157","volume":"56","author":"M Chishiki","year":"2010","unstructured":"Chishiki M, Kawasaki Y, Kaneko M, et al. A 10-year-old girl with IgA nephropathy who 5 years later developed the characteristic features of Henoch-Sch\u00f6nlein Purpura nephritis. Fukushima J Med Sci. 2010;56:157\u201361.","journal-title":"Fukushima J Med Sci"},{"key":"513_CR41","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1111\/1346-8138.13614","volume":"44","author":"S Ichiyama","year":"2017","unstructured":"Ichiyama S, Matayoshi T, Kaneko T. Successful multitarget therapy using prednisolone, mizoribine and tacrolimus for Henoch-Sch\u00f6nlein Purpura nephritis in children. J Dermatol. 2017;44:e56\u201357.","journal-title":"J Dermatol"},{"key":"513_CR42","doi-asserted-by":"crossref","first-page":"35147","DOI":"10.1074\/jbc.274.49.35147","volume":"274","author":"H Itoh","year":"1999","unstructured":"Itoh H, Komatsuda A, Wakui H, Miura AB, Tashima Y. Mammalian HSP60 is a major target for an immunosuppressant mizoribine. J Biol Chem. 1999;274:35147\u201351.","journal-title":"J Biol Chem"},{"key":"513_CR43","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1016\/j.transproceed.2018.03.030","volume":"50","author":"L Liu","year":"2018","unstructured":"Liu L, Ren B, Zhang H, et al. Population pharmacokinetic analysis of mizoribine in chinese renal transplant recipients. Transpl Proc. 2018;50:2392\u20137.","journal-title":"Transpl Proc"}],"container-title":["CEN Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-020-00513-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13730-020-00513-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-020-00513-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,3]],"date-time":"2021-08-03T23:17:56Z","timestamp":1628032676000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13730-020-00513-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,4]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["513"],"URL":"https:\/\/doi.org\/10.1007\/s13730-020-00513-6","relation":{},"ISSN":["2192-4449"],"issn-type":[{"type":"electronic","value":"2192-4449"}],"subject":[],"published":{"date-parts":[[2020,8,4]]},"assertion":[{"value":"5 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have declared that no conflicts of interest exists.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}